1.
              Krieg AM (2007) Antiinfective applications of toll-like receptor 9 agonists. Proc Am Thorac Soc 4: 28994.
        doi:
        10.1513/pats.200701-021AW.
       
                      Find this article online
                    
2.
              Abreu MT, Fukata M, Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 174: 445360. 
                      Find this article online
                    
3.
              Sommariva M, De Cecco L, De Cesare M, Sfondrini L, Mnard S, et al. (2011) TLR9-agonists oppositely modulate DNA-repair genes in tumor vesus immune cells and ehance chemotherapy effects. Cancer Res 71: 638290. 
                      Find this article online
                    
4.
              De Cesare M, Calcaterra C, Pratesi G, Gatti L, Zunino F, et al. (2008) Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy. Clin Cancer Res 14: 55128.
        doi:
        10.1158/1078-0432.CCR-08-0445.
       
                      Find this article online
                    
5.
              Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 10214.
        doi:
        10.1038/nrg2290.
       
                      Find this article online
                    
6.
              Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 21533.
        doi:
        10.1016/j.cell.2009.01.002.
       
                      Find this article online
                    
7.
              Griffiths-Jones S, Saini HK, van DS, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154D158.
        doi:
        10.1093/nar/gkm952.
       
                      Find this article online
                    
8.
              Griffiths-Jones S, Grocock RJ, van DS, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140D144.
        doi:
        10.1093/nar/gkj112.
       
                      Find this article online
                    
9.
              Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32: D109D111.
        doi:
        10.1093/nar/gkh023.
       
                      Find this article online
                    
10.
              Hermeking H (2012) MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 12: 61326.
        doi:
        10.1038/nrc3318.
       
                      Find this article online
                    
11.
              Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 5863.
        doi:
        10.1038/nature07228.
       
                      Find this article online
                    
12.
              Wu S, Huang S, Ding J, Zhao Y, Liang L, et al. (2010) Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3 untranslated region. Oncogene 29: 23028.
        doi:
        10.1038/onc.2010.34.
       
                      Find this article online
                    
13.
              Allen KE, Weiss GJ (2010) Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther 9: 312636.
        doi:
        10.1158/1535-7163.MCT-10-0397.
       
                      Find this article online
                    
14.
              Landau DA, Slack FJ (2011) MicroRNAs in mutagenesis, genomic instability, and DNA repair. Semin Oncol 38: 74351.
        doi:
        10.1053/j.seminoncol.2011.08.003.
       
                      Find this article online
                    
15.
              Hu H, Gatti RA (2011) MicroRNAs: new players in the DNA damage response. J Mol Cell Biol 3: 1518.
        doi:
        10.1093/jmcb/mjq042.
       
                      Find this article online
                    
16.
              Sommariva M, De Cecco L, Tagliabue E, Balsari A (2012) Modulation of DNA repair genes induced by TLR9 agonists. A strategy to elimate altered cells? OncoImmunology 1: 2589. 
                      Find this article online
                    
17.
              Benard J, Da Silva J, De Blois MC, Boyer P, Duvillard P, et al. (1985) Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res 45: 49709. 
                      Find this article online
                    
18.
              Wright GW, Simon RM (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19: 244855.
        doi:
        10.1093/bioinformatics/btg345.
       
                      Find this article online
                    
19.
              Sales G, Coppe A, Bisognin A, Biasiolo M, Bortoluzzi S, et al. (2010) MAGIA, a web-based tool for miRNA and Genes Integrated Analysis. Nucleic Acids Res 38: W352W359.
        doi:
        10.1093/nar/gkq423.
       
                      Find this article online
                    
20.
              Shih KK, Qin LX, Tanner EJ, Zhou Q, Bisogna M, et al. (2011) A microRNA survival signature (MiSS) for advanced ovarian cancer. Gynecol Oncol 121: 44450.
        doi:
        10.1016/j.ygyno.2011.01.025.
       
                      Find this article online
                    
21.
              Bagnoli M, De CL, Granata A, Nicoletti R, Marchesi E, et al. (2011) Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget 2: 126578. 
                      Find this article online
                    
22.
              Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 11827.
        doi:
        10.1093/biostatistics/kxj037.
       
                      Find this article online
                    
23.
              Dolezalova D, Mraz M, Barta T, Plevova K, Vinarsky V, et al. (2012) MicroRNAs regulate p21(Waf1/Cip1) protein expression and the DNA damage response in human embryonic stem cells. Stem Cells 30: 136272. 
                      Find this article online
                    
24.
              Berezikov E, Thuemmler F, van Laake LW, Kondova I, Bontrop R, et al. (2006) Diversity of microRNAs in human and chimpanzee brain. Nat Genet 38: 13757.
        doi:
        10.1038/ng1914.
       
                      Find this article online
                    
25.
              Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 26905.
        doi:
        10.1158/1078-0432.CCR-07-1731.
       
                      Find this article online
                    
26.
              Kim TH, Kim YK, Kwon Y, Heo JH, Kang H, et al. (2010) Deregulation of miR-519a, 153, and 4855p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology 57: 73443.
        doi:
        10.1111/j.1365-2559.2010.03686.x.
       
                      Find this article online
                    
27.
              Stronach EA, Alfraidi A, Rama N, Datler C, Studd JB, et al. (2011) HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer. Cancer Res 71: 441222.
        doi:
        10.1158/0008-5472.CAN-10-4111.
       
                      Find this article online
                    
28.
              Baltimore D, Boldin MP, OConnell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9: 83945.
        doi:
        10.1038/ni.f.209.
       
                      Find this article online
                    
29.
              Lodish HF, Zhou B, Liu G, Chen CZ (2008) Micromanagement of the immune system by microRNAs. Nat Rev Immunol 8: 12030. 
                      Find this article online
                    
30.
              OConnell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10: 11122.
        doi:
        10.1038/nri2708.
       
                      Find this article online
                    
31.
              Nahid MA, Satoh M, Chan EK (2011) MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 8: 388403.
        doi:
        10.1038/cmi.2011.26.
       
                      Find this article online
                    
32.
              Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 6549.
        doi:
        10.1038/ncb1596.
       
                      Find this article online
                    
33.
              Jin KL, Park JY, Noh EJ, Hoe KL, Lee JH, et al. (2010) The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells. J Gynecol Oncol 21: 2628.
        doi:
        10.3802/jgo.2010.21.4.262.
       
                      Find this article online
                    
34.
              Ozaki K, Kishikawa F, Tanaka M, Sakamoto T, Tanimura S, et al. (2008) Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs. Cancer Sci 99: 37684.
        doi:
        10.1111/j.1349-7006.2007.00669.x.
       
                      Find this article online
                    
35.
              Stiborova M, Eckschlager T, Poljakova J, Hrabeta J, Adam V, et al.. (2012) The synergistic effects of DNA-targeted chemotherapeutics and histone deacetylase inhibitors as therapeutic strategies for cancer treatment. Curr Med Chem. 
36.
              Thurn KT, Thomas S, Moore A, Munster PN (2011) Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer. Future Oncol 7: 26383.
        doi:
        10.2217/fon.11.2.
       
                      Find this article online
                    
37.
              Gryder BE, Sodji QH, Oyelere AK (2012) Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med Chem 4: 50524.
        doi:
        10.4155/fmc.12.3.
       
                      Find this article online
                    
38.
              Miska EA (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15: 5638.
        doi:
        10.1016/j.gde.2005.08.005.
       
                      Find this article online
                    
39.
              Jackson AL, Levin AA (2012) Developing microRNA Therapeutics: Approaching the Unique Complexities. Nucleic Acid Ther 22: 21325. 
                      Find this article online
                    